Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

West Virginia PEIA Renews Humana as Health Insurer for Retirees: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24514/Humana_logo.png
West Virginia PEIA Renews Humana as Health Insurer for Retirees


Humana Inc. (NYSE: HUM) has been awarded a new, four-year contract with the West Virginia Public Employee’s Insurance Agency (PEIA). As part of the contract, effective Jan. 1, 2022, Humana will

Waters Arc Premier System Delivers Increased Precision and Certainty in Chromatographic Results
Waters Arc Premier System Delivers Increased Precision and Certainty in Chromatographic Results


Waters Corporation (NYSE:WAT) today introduced the Waters™ Arc™ Premier System, the first liquid chromatography system optimized for chromatographic separations on 2.5 – 3.5 micron columns to also

Agilent Presents Thought Leader Award to Dr. Stéphane Bayen
Agilent Presents Thought Leader Award to Dr. Stéphane Bayen


Agilent Technologies Inc. (NYSE: A) today announced that Stéphane Bayen has received an Agilent Thought Leader Award. Dr. Bayen is an Associate Professor in the Department of Food Science and

Quidel Receives Amended Emergency Use Authorization for New Sofia® Q Rapid Antigen Test Device
Quidel Receives Amended Emergency Use Authorization for New Sofia® Q Rapid Antigen Test Device


Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that Quidel has

British Columbia First Province to Cover Dexcom G6 Continuous Glucose Monitoring System for People With Type 1 and Type 2 Diabetes on Intensive Insulin Therapy
British Columbia First Province to Cover Dexcom G6 Continuous Glucose Monitoring System for People With Type 1 and Type 2 Diabetes on Intensive Insulin Therapy


Dexcom, Inc. (NASDAQ: DXCM), a leader in real-time continuous glucose monitoring (CGM), announced today that people with diabetes who are on intensive insulin therapy, age two years or older, may

Quidel to Present Virtually at Raymond James Human Health Innovation Conference 2021
Quidel to Present Virtually at Raymond James Human Health Innovation Conference 2021


Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it will present at

League and Humana Partner to Digitally Transform Healthcare Experience for Millions of Members: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24514/Humana_logo.png
League and Humana Partner to Digitally Transform Healthcare Experience for Millions of Members


League, a technology-focused health company powering digital transformation in healthcare, and Humana Inc. (NYSE: HUM), a leading health and well-being company, today announced an agreement to

Pfizer and BioNTech to Provide 500 Million Doses of COVID-19 Vaccine to U.S. Government for Donation to Poorest Nationshttp://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo
Pfizer and BioNTech to Provide 500 Million Doses of COVID-19 Vaccine to U.S. Government for Donation to Poorest Nations


Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced plans to provide the U.S. government at a not-for-profit price 500 million doses of the companies’ COVID-19 vaccine, 200

CenterWell Senior Primary Care to Open Six Senior-Focused Care Centers in Atlanta: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24514/Humana_logo.png
CenterWell Senior Primary Care to Open Six Senior-Focused Care Centers in Atlanta


CenterWell Senior Primary Care will open six new senior-focused primary care centers in metro Atlanta through 2022, marking the company’s debut in the Atlanta market, giving local seniors access to

Humana Names Carolyn Tandy Chief Inclusion and Diversity Officer
Humana Names Carolyn Tandy Chief Inclusion and Diversity Officer


Leading health and well-being company Humana Inc. (NYSE: HUM) has named Carolyn Tandy to the position of Senior Vice President and Chief Inclusion and Diversity Officer. Tandy will be responsible

U.S. FDA Approves PREVNAR 20™, Pfizer’s Pneumococcal 20-valent Conjugate Vaccine for Adults Ages 18 Years or Olderhttp://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo
U.S. FDA Approves PREVNAR 20™, Pfizer’s Pneumococcal 20-valent Conjugate Vaccine for Adults Ages 18 Years or Older


Pfizer Inc. (NYSE:PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved PREVNAR 20 (Pneumococcal 20-valent Conjugate Vaccine) for the prevention of invasive disease

Waters Sets New Standard in High Resolution Mass Spectrometry with SELECT SERIES Multi Reflecting Time-of-Flight Platform
Waters Sets New Standard in High Resolution Mass Spectrometry with SELECT SERIES Multi Reflecting Time-of-Flight Platform


Waters Corporation (NYSE:WAT) today introduced the Waters™ SELECT SERIES™ MRT, a high-resolution mass spectrometer that combines Multi Reflecting Time-of-Flight (MRT) technology with both enhanced

Dexcom richtet den Blick auf die Zukunft der kontinuierlichen Blutzuckermessung: https://mms.businesswire.com/media/20191106005764/en/685171/5/Dexcom_Registered_no_bug.jpg
Dexcom richtet den Blick auf die Zukunft der kontinuierlichen Blutzuckermessung


DexCom, Inc. (Nasdaq: DXCM), der Weltmarktführer im Bereich der kontinuierlichen Blutzuckermessung in Echtzeit für Menschen mit Diabetes, hat heute während der 14. Internationalen Konferenz über

Cell-Free DNA Guided Targeted Therapy Leads to Better Survival in Advanced Non-Small Cell Lung Cancerhttps://www.cyansecurity.com/:
Cell-Free DNA Guided Targeted Therapy Leads to Better Survival in Advanced Non-Small Cell Lung Cancer


Agilent Technologies Inc. (NYSE: A) today announced a presentation by Memorial Sloan Kettering Cancer Center (MSK) at the upcoming annual meeting of the American Society of Clinical Oncology (ASCO)

Dexcom Looks to the Future of Continuous Glucose Monitoring: https://mms.businesswire.com/media/20191106005764/en/685171/5/Dexcom_Registered_no_bug.jpg
Dexcom Looks to the Future of Continuous Glucose Monitoring


DexCom, Inc. (Nasdaq: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today the publication and presentation of two new studies during the 14

PQA Presents CarePlus Health Plans with its Excellence in Quality Award: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24514/Humana_logo.png
PQA Presents CarePlus Health Plans with its Excellence in Quality Award


CarePlus Health Plans, Inc., Florida’s largest* 5 out of 5-star Medicare Advantage plan, has been recognized by the Pharmacy Quality Alliance (PQA) with its Excellence in Quality award for

Agilent Announces New SureSelect Human All Exon V8:
Agilent Announces New SureSelect Human All Exon V8


Agilent Technologies Inc. (NYSE: A) today announced the release of SureSelect Human All Exon V8 – a new exome design that provides comprehensive content and up-to-date coverage of protein coding

CenterWell Senior Primary Care Extends its Value-Based Care to People with Original Medicare: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24514/Humana_logo.png
CenterWell Senior Primary Care Extends its Value-Based Care to People with Original Medicare


CenterWell Senior Primary Care, a fast-growing provider of whole-person, senior-focused healthcare, is participating in a new federal population health program that will allow CenterWell to extend

Agilent Presents Thought Leader Award to Professor Chris Elliott
Agilent Presents Thought Leader Award to Professor Chris Elliott


Agilent Technologies Inc. (NYSE: A) today announced that Chris Elliott has received an Agilent Thought Leader Award. Dr. Elliott is Professor of Food Safety in the School of Biological Sciences and

Illumina Supports Nationwide Program across Belgium to Assess Whole Genome Sequencing for Developmental Disorders Diagnosis
Illumina Supports Nationwide Program across Belgium to Assess Whole Genome Sequencing for Developmental Disorders Diagnosis


Today, Illumina, Inc. (NASDAQ:ILMN) announced an agreement with the Belgian Genetic Centers to evaluate whole-genome sequencing (WGS) for the diagnosis of patients with intellectual disabilities

Illumina and Next Generation Genomic Partner to Launch VeriSeq™ NIPT Solution in Thailand
Illumina and Next Generation Genomic Partner to Launch VeriSeq™ NIPT Solution in Thailand


Illumina, Inc., the global leader in DNA sequencing and array-based technologies and Next Generation Genomic Co., Ltd. (NGG Thailand), the Association of Southeast Asian Nations (ASEAN) leaders in

Illumina To Webcast Upcoming Investor Conference
Illumina To Webcast Upcoming Investor Conference


Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conference:




  • Goldman Sachs 42nd Annual Global Healthcare Conference on June 10, 2021

Humana Ranks #1 in J.D. Power Commercial Member Health Plan Study for Second Consecutive Year in Florida and Texas: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24514/Humana_logo.png
Humana Ranks #1 in J.D. Power Commercial Member Health Plan Study for Second Consecutive Year in Florida and Texas


Leading health and well-being company Humana Inc. (NYSE: HUM) announced today that for the second consecutive year, it is ranked #1 in Florida and Texas in the J.D. Power ranking of Commercial

Dexcom Announces Upcoming Conference Presentation: https://mms.businesswire.com/media/20191106005764/en/685171/5/Dexcom_Registered_no_bug.jpg
Dexcom Announces Upcoming Conference Presentation


DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on Dexcom at the following upcoming investor conference:




  • Jereme Sylvain, Executive Vice President and Chief

Agilent Reports Second-Quarter Fiscal Year 2021 Financial Results:
Agilent Reports Second-Quarter Fiscal Year 2021 Financial Results


Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.525 billion for the second quarter ended April 30, 2021, an increase of 23% compared to the second quarter of 2020 and up 19% on a